Gene-Based Nanoparticles Show Efficacy in Stargardt Treatment
Researchers identify potential nonviral gene therapy to combat the disease.
Researchers identify potential nonviral gene therapy to combat the disease.
Using animal models, researchers determine subarachnoid hemorrhage can lead to new vessel development and the reduction of ganglion cells.
These tools can provide insight into patients’ IOP profiles outside of office hours.
Study shows reductions in intraocular pressures and antiglaucoma medication use.
A small study shows efficacy in the OCT-A imaging of patients’ subfoveal choroidal thickness.
The combination of 5 visual analogue scales offers accurate assessment of dry eye disease burden.
Investigators suggest the drug may play a role in preventing disease progression.
Researchers investigate the use of a customized corneal crosslinking approach that employs a transepithelial approach with supplemental oxygen to treat of progressive keratoconus.
The treatment can help improve central macular thickness and visual acuity for patients with diabetic macular edema.
Researchers consider the potential for Ang2 as a target for antiangiogenic agents in treatment of the disease.